AMP Has Strong Presence At FDA Workshop On Ldts, Delivers Message Of Optimizing Patient Care Through Molecular Diagnostics

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals, will speak at the U.S. Food and Drug Administration’s (FDA) Public Workshop, Framework for Regulatory Oversight of LDTs, Jan. 8-9, 2015. During the two day event, representatives from AMP’s leadership will join other stakeholders in providing feedback on the FDA draft guidance titled “Draft Guidance for Industry, Food and Drug Administration Staff, and Clinical Laboratories; Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)”.

Help employers find you! Check out all the jobs and post your resume.